MICCN signs MOU with Harvard's Brigham and Women's Hospital
The Monash Institute of Cognitive and Clinical Neurosciences (MICCN) has secured its fifth international Memorandum of Understanding (MOU), this time with the prestigious Brigham and Women's Hospital (BWH), an international leader in medical research and a teaching hospital of Harvard Medical School located in Boston, United States.
BWH is recognised internationally for excellence and innovation in biomedical research, and education and training programs for physicians, scientists and healthcare professionals. It is consistently ranked among the best in specialty areas including neurology and neurosurgery - with US$640 million in research funding, 1,000+ principal investigators, over 3,700 researchers. The Division of Sleep and Circadian Disorders at the BWH has a distinguished history in the fields of sleep and circadian rhythm research and an advanced program of clinical care as well as basic scientific and patient-oriented research.
[Pictured: Professor Shantha Rajaratnam (top row left), Professor Steven Lockley (top row right), Professor Charles A. Czeisler (Chief, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Director, Division of Sleep Medicine, Harvard Medical School; front row left) and Professor Kim Cornish (front row right)]
On 2 June 2017, MICCN crossed continents to officially join forces with BWH. The MOU will foster joint research projects, student and staff exchanges, and enhance international entrepreneurial endeavours for both partners.
“The Brigham and Women's Hospital’s sleep research mission is strongly aligned with MICCN’s strategies in this area,” said Professor Shantha Rajaratnam, MICCN’s Sleep Program Lead and Deputy Head of the Monash School of Psychological Sciences. “We already have strong, collaborative ties with BWH, with many of MICCN’s Sleep researchers trained at BWH and Harvard. The MOU will be the next phase in this partnership, enabling us to increase staff and student exchanges, undertake collaborative research grants, and much more. It is a very exciting and promising time, and we look forward to working even more closely with some of the world’s best research minds to deliver life-changing breakthroughs.”